ARC Actions Biotech is an open-end fund registered in France.The objective of the Fund is to outperform the Nasdaq Biotech index. The Fund invests at least 70 % of its assets in stocks linked to the biotechnology and health technologies sectors. Investments are not restricted in terms of market capitalization or geographic region, however most investments are made in North American equities.
Financiere de l'Arc
260, Rue Guillaume du Vair